发明名称 NON-MUCOADHESIVE FILM DOSAGE FORMS
摘要 Orally disintegrating film dosage forms for delivering active pharmaceutical agents, methods of formulating the dosage forms to retard absorption through the oral mucosa, and methods of using the dosage forms for the treatment of various medical conditions are provided.
申请公布号 US2016022574(A1) 申请公布日期 2016.01.28
申请号 US201514658907 申请日期 2015.03.16
申请人 LABTEC GESELLSCHAFT FUR TECHNOLOGISCHE FORSCHUNG UND ENTWICKLUNG MBH ;APR APPLIED PHARMA RESEARCH S.A. 发明人 Leichs Christian;Breitenbach Armin;Lehrke Ingo;Galfetti Paolo
分类号 A61K9/00;A61K31/4178;A61K31/196;A61K31/137;A61K31/485;A61K31/375;A61K31/573;A61K31/522;A61K31/4015;A61K31/4535;A61K31/495;A61K31/4045;A61K31/166;A61K31/13;A61K31/551;A61K31/5415;A61K31/519;A61K31/4402;A61K31/4172;A61K31/445 主分类号 A61K9/00
代理机构 代理人
主权项 1) A non-mucoadhesive orally disintegrating film, able to disintegrate upon contact with saliva in the buccal cavity within about sixty seconds, comprising donepezil or a pharmaceutically acceptable salt thereof in combination with a hydrophilic binder and a water-soluble diluent, wherein: a) said film is characterized predominantly by gastrointestinal absorption when placed on the tongue, allowed to disintegrate, and subsequently swallowed; b) said film comprises from about 2.5 to about 20 mg of donepezil or a pharmaceutically acceptable salt thereof; c) said donepezil hydrochloride is present in an amount of from about 0.05% to about 50% (w/w), based on the total weight of the film, d) said film has a Tmax of from about 3 to about 4 hours, and e) said donepezil or pharmaceutically acceptable salt thereof has an absolute bioavailability in said film of about 100%.
地址 Langenfeld DE